Core support for the Africa Centre. (360G-Wellcome-079433_Z_06_A)

£42,795

The epidemiology of tsetse-transmitted human or livestock trypanosomiasis is to a large extend determined by tsetse density, infection rate and host preference. & nbsp; All three contributing factors vary between tsetse populations and within a tsetse population may, often due to differences in the well-being of the tsetse population, vary in time and space. & nbsp; A major factor, contributing to tsetse population stress is human encroachment and concomitant fragmentation of tsetse habitat as a result of the introduction and expansion of mixed farming systems. & nbsp; Understanding the impact of habitat fragmentation on the tsetse population may contribute to the development of more effective control strategies. & nbsp; Riparian and savannah tsetse species play the major role in disease transmission. Therefore, the project will identify study areas in West and southern Africa, where each group is predominant. & nbsp; In those study areas, the fragmentation of riparian vegetation and savannah woodland will be quantified and qualified using environmental and remotely sensed data. & nbsp; Study sites with different degrees of fragmentation will be identified and the tsetse and livestock populations will be monitored. & nbsp; Special attention will go to parameters that can be used to develop population dynamics and disease transmission models. The models will be used to determine (i) the well-being, dynamics and vulnerability of tsetse sub-populations in fragmented habitats, and (ii) & nbsp; the infection rate of hosts and vectors and the related disease transmission risk. Furthermore, analyses of genetic diversity and gene flow between tsetse populations in habitat fragments will make it possible to determine the effect of different levels of fragmentation on the tsetse & rsquo;s dispersal capacity. & nbsp; This may result in the identification of isolated tsetse populations. & nbsp; Using the findings of the field studies various control approaches will be tested and their appropriateness assessed. The outcomes of the study will be translated into practical guidelines that will facilitate the selection of priority areas for control and the most appropriate control method(s). & nbsp; The guidelines will be transferred to the beneficiaries.

Where is this data from?

This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.

Grant Details

Amount Awarded 42795
Applicant Surname Newell
Approval Committee Populations and Public Health Funding Committee
Award Date 2006-02-08T00:00:00+00:00
Financial Year 2005/06
Grant Programme: Title Africa and Asia Programmes
Internal ID 079433/Z/06/A
Lead Applicant Prof Marie-Louise Newell
Partnership Value 42795
Planned Dates: End Date 2011-01-17T00:00:00+00:00
Planned Dates: Start Date 2006-01-18T00:00:00+00:00
Recipient Org: Country United Kingdom
Region Greater London